Meridian Bioscience Inc. (VIVO) Monday said it received U.S. FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.
Group A Streptococcus is a bacteria commonly found in the human throat or on skin and causes a diseases in humans such as acute pharyngitis or strep throat.
The company said illumigene Group A Strep represents a significant new advancement in healthcare by providing a molecular solution for the detection of Group A Strep pharyngitis.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.